Media Resources


Statement to WHA77 – Substance Use Disorder

Statement to WHA77 – Climate change and health

Statement to WHA77 – AMR: Accelerating national and global responses

Statement to WHA77- Universal Health Coverage

Statement to 8th Meeting of the WGIHR

INB 9 – HAI Statement

INB 8 – WGIHR – HAI Statement

INB 8 – HAI Statement

Statement to EB154 – Economics and Health for All

Statement to EB154 – Antimicrobial Resistance

Statement to EB154 – Universal Health Coverage


Statement to INB 7 on Pandemic PPR

HAI Response to EMA Real-World Evidence Consultation

HAI Response Public Consultation on EMA AI Reflection Paper

Statement to INB/IHR Plenary Session

Statement to the Fifth Meeting of the Intergovernmental Negotiating Body

Statement to WHA76 – UHC

Statement to WHA76 – Health Emergencies

Joint Statement on the Impact of Artificial Intelligence on Health Outcomes for Key Populations: Navigating Health Inequalities in the EU

Statement to US International Trade Commission Public Hearing on COVID-19

WHO EURO Access to Novel Medicines Platform

Statement following latest session of the European Parliament’s COVI Committee

Statement to the Fourth Meeting of the Intergovernmental Negotiating Body – Consideration and Negotiation of the Zero Draft of the WHO Convention

Statement to the 152nd WHO Executive Board – Falsified and Substandard Medicines

Lack of diagnostic use hampering fight against antimicrobial resistance


Statement to WHO Euro RC72

HAI and Partners Launch SHARP Project

HAI Statement on Tentative Agreement on TRIPS and COVID-19

Statement to EB150: Global Strategy & Plan of Action

Statement to EB150: Pandemic Preparedness and Response